Process for the manufacture of a product from a plant material

1. A process for the manufacture of a phytate depleted product from a plant material comprising the steps of:

providing a disrupted plant material in dry form, the disrupted plant material comprising <10% (w/w) starch and <10% (w/w) oil/lipids;

suspending the disrupted plant material in acid at a value of pH 3.0 or below preheated to an increased temperature in the range of 60° C. to 80° C. to provide a heated, acidic suspension; and

isolating the phytate depleted product from the heated, acidic suspension.

2. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the pH is in the range of 1.0 to 2.5.

3. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the pH is adjusted with an acid capable of serving as a chelating agent.

4. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the acid comprises an acid selected from the group consisting of citric acid, oxalic acid, lactic acid, malic acid, maleonic acid, tartaric acid, succinic acid or a combination thereof.

5. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the acidic suspension is buffered.

6. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the plant material is derived from a legume.

7. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the plant material is derived from potatoes.

8. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the plant material is suspended in liquid at about 50 g/L to about 500 g/L.

9. The process for the manufacture of a phytate depleted product according to claim 1 , wherein the duration of the period the plant material is maintained at the increased temperature is from about 1 minute to about 10 minutes.

10. The process for the manufacture of a phytate depleted product according to claim 1 , wherein no phytase enzyme or phytase enzyme inhibitor is added.

11. A process for the manufacture of a phytate depleted product according to claim 1 , further comprising the steps of:

subjecting the heated, acidic suspension to a solid-liquid separation to provide an acid precipitated fraction and an acid soluble liquid fraction;

isolating an insoluble fibre product or a protein isolate product from the acid precipitated fraction; and/or

suspending the acid precipitated fraction in a liquid and adjusting the pH to a value above pH 4.9 to provide an alkaline suspension;

subjecting the alkaline suspension to a solid-liquid separation to provide an alkaline precipitated fraction and an alkaline soluble liquid fraction;

isolating the phytate depleted product as a fibre isolate product from the alkaline precipitated fraction.

12. A process for the manufacture of a phytate depleted product according to claim 1 , further comprising the steps of:

adjusting the pH of the heated, acidic suspension to a value from 4.0 to 6.0 to provide a neutral suspension;

isolating the product from the neutral suspension; and/or

subjecting the neutral suspension to a solid-liquid separation to provide a neutral precipitate and a neutral supernatant;

isolating the phytate depleted product as a protein isolate product from the neutral precipitate.

13. A process for the manufacture of a phytate depleted product according to claim 11 , further comprising the steps of:

adjusting the pH of the acid soluble liquid fraction or the alkaline soluble liquid fraction to a value from 4.0 to 6.0 to provide a neutral suspension;

isolating the product from the neutral suspension; and/or

subjecting the neutral suspension to a solid-liquid separation to provide a neutral precipitate and a neutral supernatant;

isolating the phytate depleted product as a protein isolate product from the neutral precipitate.

14. A process for the manufacture of a phytate depleted product according to claim 1 , further comprising the steps of:

optionally adjusting the pH of the heated, acidic suspension to a value from 3.0 to 4.0;

contacting the heated acidic suspension with a cation-exchange chromatography resin to separate a cationic binding fraction from a cationic non-binding fraction;

contacting the cation-exchange chromatography resin with an eluent solution to elute the phytate depleted product as a protein concentrate product or as a protein isolate product or as a glycoalkaloid product or as an alkaloid product from the cationic binding fraction from the cation-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product, or as a carbohydrate product from the cationic non-binding fraction; and/or

optionally adjusting the pH of the cationic non-binding fraction to a value from 7.0 to 9.0;

contacting the cationic non-binding fraction with an anion-exchange chromatography resin to separate an anionic binding fraction from an anionic non-binding fraction;

contacting the anion-exchange chromatography resin with an eluent solution to elute a phytate product or a saponin product or a phenolic product from the anionic binding fraction from the anion-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product or as a carbohydrate product or as an alkaloid product or as a glycoalkaloid product from the anionic non-binding fraction.

15. A process for the manufacture of a phytate depleted product according to claim 11 , further comprising the steps of:

optionally adjusting the pH of the alkaline suspension, or the acid or the alkaline soluble liquid fraction to a value from 3.0 to 4.0;

contacting the alkaline suspension, or the acid or the alkaline soluble liquid fraction with a cation-exchange chromatography resin to separate a cationic binding fraction from a cationic non-binding fraction;

contacting the cation-exchange chromatography resin with an eluent solution to elute the phytate depleted product as a protein concentrate product or as a protein isolate product or as a glycoalkaloid product or as an alkaloid product from the cationic binding fraction from the cation-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product, or a carbohydrate product from the cationic non-binding fraction; and/or

optionally adjusting the pH of the cationic non-binding fraction to a value from 7.0 to 9.0;

contacting the cationic non-binding fraction with an anion-exchange chromatography resin to separate an anionic binding fraction from an anionic non-binding fraction;

contacting the anion-exchange chromatography resin with an eluent solution to elute a phytate product or a saponin product or a phenolic product from the anionic binding fraction from the anion-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product or as a carbohydrate product or an alkaloid product or as a glyco alkaloid product from the anionic non-binding fraction.

16. A process for the manufacture of a phytate depleted product according to claim 12 , further comprising the steps of:

optionally adjusting the pH of the neutral suspension or the neutral supernatant to a value from 3.0 to 4.0;

contacting the neutral suspension or the neutral supernatant with a cation-exchange chromatography resin to separate a cationic binding fraction from a cationic non-binding fraction;

contacting the cation-exchange chromatography resin with an eluent solution to elute the phytate depleted product as a protein concentrate product or as a protein isolate product or as a glycoalkaloid product or as an alkaloid product from the cationic binding fraction from the cation-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product, or as a carbohydrate product from the cationic non-binding fraction; and/or

optionally adjusting the pH of the cationic non-binding fraction to a value from 7.0 to 9.0;

contacting the cationic non-binding fraction with an anion-exchange chromatography resin to separate an anionic binding fraction from an anionic non-binding fraction;

contacting the anion-exchange chromatography resin with an eluent solution to elute a phytate product or a saponin product or a phenolic product from the anionic binding fraction from the anion-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product or as a carbohydrate product or an alkaloid product or as a glyco alkaloid product from the anionic non-binding fraction.

17. A process for the manufacture of a phytate depleted product according to claim 13 , further comprising the steps of:

optionally adjusting the pH of the neutral suspension or the neutral supernatant to a value from 3.0 to 4.0;

contacting the neutral suspension or the neutral supernatant with a cation-exchange chromatography resin to separate a cationic binding fraction from a cationic non-binding fraction;

contacting the cation-exchange chromatography resin with an eluent solution to elute the phytate depleted product as a protein concentrate product or as a protein isolate product or as a glycoalkaloid product or as an alkaloid product from the cationic binding fraction from the cation-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product, or as a carbohydrate product from the cationic non-binding fraction; and/or

optionally adjusting the pH of the cationic non-binding fraction to a value from 7.0 to 9.0;

contacting the cationic non-binding fraction with an anion-exchange chromatography resin to separate an anionic binding fraction from an anionic non-binding fraction;

contacting the anion-exchange chromatography resin with an eluent solution to elute a phytate product or a saponin product or a phenolic product from the anionic binding fraction from the anion-exchange chromatography resin; and/or

isolating the phytate depleted product as a soluble fibre product or as a carbohydrate product or as an alkaloid product or as a glycoalkaloid product from the anionic non-binding fraction.

18. The process for the manufacture of a phytate depleted product according to claim 11 , wherein the solid-liquid separation is selected from filtration or centrifugation or a combination of filtration and centrifugation.